4 1 stephen_f4-101802.txt ------------------------------ OMB APPROVAL [ ] Check this box if no longer ------------------------------ subject to Section 16. Form 4 or OMB Number 3235-0287 Form 5 obligations may continue. Expires: January 31, 2005 See Instruction 1(b). Estimated average burden hours per response ....... 0.5 ------------------------------ U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4 STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 -------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* Levine, Stephen A. -------------------------------------------------------------------------------- (Last) (First) (Middle) 30806 Santana Street -------------------------------------------------------------------------------- (Street) Hayward, California 94544 -------------------------------------------------------------------------------- (City) (State) (Zip) -------------------------------------------------------------------------------- 2. Issuer Name and Ticker or Trading Symbol Allergy Research Group, Inc. (ALRG) -------------------------------------------------------------------------------- 3. IRS Identification Number of Reporting Person, if an entity (voluntary) -------------------------------------------------------------------------------- 4. Statement for Month/Day/Year October 18, 2002 -------------------------------------------------------------------------------- 5. If Amendment, Date of Original (Month/Day/Year) -------------------------------------------------------------------------------- 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) [X] Director [X] 10% Owner [X] Officer (give title below) [_] Other (specify below) Chief Executive Officer, Chief Financial Officer, President and Chairman of the Board -------------------------- -------------------------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check Applicable Line) [X] Form filed by One Reporting Person [_] Form filed by More than One Reporting Person -------------------------------------------------------------------------------- ================================================================================ Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned ================================================================================

6. 4. 5. Owner- 2A. Securities Acquired (A) or Amount of ship 2. Deemed 3. Disposed of (D) Securities Form: 7. Trans- Execu- Transaction (Instr. 3, 4 and 5) Beneficially Direct Nature of action tion Code ------------------------------- Owned Following (D) or Indirect 1. Date Date, (Instr. 8) (A) Reported Indirect Beneficial Title of Security (mm/dd/ if any ------------ Amount or Price Transaction(s) (I) Ownership (Instr. 3) Year) (mm/dd/yy) Code V (D) (Instr. 3 and 4) (Instr.4) (Instr. 4) ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 0810/3018/02 10/21/02 P 1513,500 (A) $0.255 10,~~037~~103,250 Common (D) Shares ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================

FORM 4 (continued) Table II -- DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED (e.g., puts, calls, warrants, options, convertible securities) ================================================================================

Explanation of Responses: /s/ Stephen A. Levine 11/15/02 --------------------------------------------- ----------------------- **Signature of Reporting Person Date Reminder: Report on separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, See Insruction 4(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. Page 2

Filing Compare · ALLERGY RESEARCH GROUP INC